Skip to main content
Loading

Analytical method transfer: robust assays, reproducibility, and tech transfer pitfalls

08 Sept 2026
Cell Therapy Manufacturing

1). What are the main challenges we face when getting into late phase cell and gene therapy product development? 

2) What are some "wins" within cell therapy analytical development? 

3) Discuss potency strategies.

Industry Expert
Jigesha Dholakia, Director CMC Analytical Strategy - Bayer